ArticleGastroenterology2012
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutics targets for tyrosine kinase inhibitors.
Giovanni Brandi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it